I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 7 studies | 25% ± 6% | |
| B cell | 6 studies | 24% ± 8% | |
| natural killer cell | 6 studies | 24% ± 8% | |
| endothelial cell | 6 studies | 21% ± 5% | |
| epithelial cell | 6 studies | 30% ± 14% | |
| non-classical monocyte | 4 studies | 35% ± 18% | |
| CD8-positive, alpha-beta T cell | 4 studies | 27% ± 7% | |
| leukocyte | 3 studies | 19% ± 3% | |
| naive thymus-derived CD4-positive, alpha-beta T cell | 3 studies | 25% ± 5% | |
| classical monocyte | 3 studies | 33% ± 12% | |
| effector memory CD8-positive, alpha-beta T cell | 3 studies | 31% ± 6% | |
| mature NK T cell | 3 studies | 21% ± 4% | |
| microglial cell | 3 studies | 20% ± 3% | |
| squamous epithelial cell | 3 studies | 28% ± 15% | |
| basal cell | 3 studies | 25% ± 5% | |
| gamma-delta T cell | 3 studies | 29% ± 4% | |
| transit amplifying cell | 3 studies | 22% ± 4% | |
| plasmacytoid dendritic cell | 3 studies | 19% ± 3% |
